(2013) 'Unexpected low temperature behaviour of piroxicam monohydrate. ', ChemPhysChem., 14 (4). pp.
675-679.Further information on publisher's website:
Use policyThe full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that:• a full bibliographic reference is made to the original source • a link is made to the metadata record in DRO • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders.Please consult the full DRO policy for further details.
MonohydrateKatharina Fucke, [a] Alison J. Edwards, [b] Michael R.Probert, [a] Sarah E. Tallentire, [a] Judith A. K. Howard, [a] and Jonathan W. Steed* [a] Pharmaceutical compounds can crystallise in different polymorphic forms with the same chemical composition; a phenomenon that has been studied for almost 200 years, [1] and remains a major issue in the pharmaceutical industry. Additional problems arise from solvated crystal forms, which incorporate one or more types of solvent from the crystallisation medium into the crystal. [2] In the special case of water incorporation, the crystal form is called a hydrate. Pharmaceutical hydrates, which can vary widely in both composition and stability, are simultaneously favoured and feared. Hydrates exhibit the lowest solubility in water of all crystal forms of a compound and hence hydrate formation can seriously influence the bioavailability and thus the safety and efficacy of a medication.[3] As a result there is considerable current interest in the study of water clusters in crystalline hydrates. [4] Hydrated crystal structures also shed light on the fundamental nature of homomeric interactions between water molecules and heteromeric interactions between water and host molecules in molecular solids. [4b, 5] With the help of modern diffraction techniques and computational studies, these interactions can now be accurately structurally characterised, [6] making essential information available for ab initio crystal structure prediction of hydrates. [7] We have focussed on the neutron structural characterisation of a range of pharmaceutically relevant hydrates. [5b, 8] As part of this study we have investigated piroxicam (PIR, Figure 1), which is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of chronic pain in rheumatoid arthritis and osteoarthritis. PIR is listed in both the European [9] and the US Pharmacopoeias, [10] and is reported to exist in three different unsolvated crystal forms, [11] a monohydrate, [12] and several multicomponent crystals and salt forms. [13] Our interest lies mainly in the interaction of water of crystallisation with the host molecule in the monohydrate structure. We now report accurate hydrogen atom positions for PIR monohydrate derived from neutron diffraction data as well as the substance's remarkable behaviou...